Sign up to see all 5.
Sign up to see all 3.
No insider has filed a notice of proposed sale (Form 144) for Ensysce Biosciences Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
JS
Jane Street Group, LLC
|
208.8K | 1.07% | +195.3K (+1438.9%) | Q1 '26 | 0.0% | |
|
Shares held by quarter
Peak holding208.8K (Q2'26)
Change over 8 quarters+208.8K
Share of the company1.070%
|
||||||
|
AC
Adage Capital Partners GP, L.L.C.
|
149.7K | 0.77% | Unchanged | 2024 | 0.0% | |
|
Shares held by quarter
Peak holding149.7K (Q4'25)
Change over 8 quarters+149.7K
Share of the company0.770%
|
||||||
17 more super investors behind a free account
See every manager holding Ensysce Biosciences Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FE
Fidelity Concord Street Trust
|
$23.8K | 60.7K | 0.31% | 0.00% | August 31, 2026 |
|
VE
Vanguard Index Funds
|
$3.73K | 12.9K | 0.07% | 0.00% | June 30, 2026 |
1 more funds behind a free account
See every fund holding Ensysce Biosciences Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BG
Bob Gene Gower
5%+ holder
13D · 6.1%
|
1.2M | 6.20% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...